Signadori Bio

Signadori Bio
Developing a next-generation, off-the-shelf, in vivo engineered monocyte immunotherapy platform for solid tumors.
About
What does Signadori Bio do?
Signadori Bio SAS is a preclinical-stage biopharmaceutical company focused on developing an innovative immunotherapy platform. Their approach utilizes in vivo engineered monocytes, designed to be an off-the-shelf solution for treating solid tumors. The company aims to advance novel therapeutic strategies in oncology.
What is Signadori Bio's revenue?
StartupHub estimates Signadori Bio's annual revenue at $1.5M (range $308K to $4.4M, 35% confidence), based on comparable companies in the sector.
What is Signadori Bio's valuation?
StartupHub estimates Signadori Bio's effective valuation at $47.6M (range $30.5M to $73.2M, 24% confidence), based on comparable companies in the sector.
How much funding has Signadori Bio raised?
Signadori Bio has raised a total of $12M in funding. The most recent round on record is Seed Extension.
Where is Signadori Bio headquartered?
Signadori Bio is headquartered in Paris, France.
When was Signadori Bio founded?
Signadori Bio was founded in 2025.
What industry does Signadori Bio operate in?
Signadori Bio operates in Biotechnology, Pharmaceuticals, Oncology, Immunotherapy, Biopharmaceuticals, Drug Discovery.
What is Signadori Bio's current status?
Signadori Bio's current operating status is: Inactive.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.
A deep-tech company developing nanorobotic solutions for healthcare, initially targeting dental care applications.
MatrixCode is a research focus at the Freiburg Institute for Advanced Studies (FRIAS) investigating matrisome pathology.
A company focused on privacy, Zcash accumulation, and developing cancer therapeutics.
An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.
